Skip to content
info@hlthcommunications.com
Instagram
Linkedin
X-twitter
About
Services
Content Strategy & Design
Events
Investor Relations
Media Relations
Social Media
Thought Leadership
Case Studies
Press
Podcast
About
Services
Content Strategy & Design
Events
Investor Relations
Media Relations
Social Media
Thought Leadership
Case Studies
Press
Podcast
About
Services
Thought Leadership
Case Studies
Enveric Biosciences
Press
Podcast
Contact
About
Services
Thought Leadership
Case Studies
Enveric Biosciences
Press
Podcast
Contact
Get In Touch
About
Services
Content Strategy & Design
Events
Investor Relations
Media Relations
Social Media
Thought Leadership
Case Studies
Press
Podcast
About
Services
Content Strategy & Design
Events
Investor Relations
Media Relations
Social Media
Thought Leadership
Case Studies
Press
Podcast
About
Services
Thought Leadership
Case Studies
Enveric Biosciences
Press
Podcast
Contact
About
Services
Thought Leadership
Case Studies
Enveric Biosciences
Press
Podcast
Contact
Get In Touch
Mentions in the Press
Highlighting Our Clients' Media Coverage
See how our clients are making headlines with impactful stories and expert insights featured in top-tier media outlets.
Will The 2024 UK Election Impact Social Housing and Supported Living Investments?
Read Now
Millennials are rapidly getting richer
Read Now
Biotech megadeals: Exploring the surge in $100M+ deals
Read Now
Psychedelic Community Reacts To FDA Committee’s Critique Of Lykos’ MDMA Studies
Read Now
Meds For Depression, Anxiety, Addiction Producer Trims Q1 Net Loss YoY, Increases Cash On Hand
Read Now
Finding The Right Patients For Ketamine Clinical Trials
Read Now
Psychedelics for Depression: MindBio and Enveric’s Joint Efforts
Read Now
Enveric Biosciences to out-license psilocin prodrug to MindBio
Read Now
Major deals continue positive trajectory in 2024
Read Now
Psychedelics Biotech Signs $66.5M Non-Binding Deal To Out-License Novel Psilocin Prodrug Candidate
Read Now
Previous
Next
